REFERÊNCIAS

  1. Brozek JL, Bousquet J, Baena-Cagnani CE, et al.

    Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision.

    J Allergy Clin Immunol. 2010;126(3):466-76

  2. Seidaman MD, Gurgel RK, Lin SY, et al.

    Clinical practice guideline: Allergic rhinitis.

    Otolaryngol Head Neck Surg. 2015;152(1 Suppl):S1-43.

  3. Wallace DV, Dykewicz MS, Oppenheimer J, et al.

    Pharmacologic Treatment of Seasonal Allergic Rhinitis: Synopsis of Guidance From the 2017 Joint Task Force on Practice Parameters.

    Ann Intern Med. 2017;167(12):876–881.

  4. Wise SK, Lin SY, Toskala E, et al.

    International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

    Int Forum Allergy Rhinol. 2018;8(2):108–352.

  5. Weinstein S, Qaqundah P, Georges G, et al.

    Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension. Ann Allergy Asthma Immunol.

    2009;102(4):339-347.

  6. Schenkel EJ, Gross G, Jacobson K, et al.

    Triamcinolone Acetonide Aqueous Nasal Inhaler for the Treatment of Spring Grass Seasonal Allergic Rhinitis in Children.

    Pediatr Asthma Allergy Immunol. 1997; 11(2):129–136.

  7. Skoner DP, Berger WE, Gawchik SM, et al.

    Intranasal triamcinolone and growth velocity.

    Pediatrics. 2015;135(2):e348-356.